Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Pharmacologic Ascorbate Radiosensitizes Pancreatic Cancer but Radioprotects Normal Tissue: The Role of Oxidative Stress-Induced Lipid Peroxidation.
Journal: Antioxidants (Basel, Switzerland)
Published: January 24, 2024
Pharmacologic Ascorbate and DNMT Inhibitors Increase DUOX Expression and Peroxide-Mediated Toxicity in Pancreatic Cancer.
Journal: Antioxidants (Basel, Switzerland)
Published: July 13, 2023
Pharmacological ascorbate induces sustained mitochondrial dysfunction.
Journal: Free radical biology & medicine
Published: April 04, 2023
Pharmacological Ascorbate Enhances Chemotherapies in Pancreatic Ductal Adenocarcinoma.
Journal: Pancreas
Published: September 13, 2022
Auranofin and Pharmacologic Ascorbate as Radiomodulators in the Treatment of Pancreatic Cancer.
Journal: Antioxidants (Basel, Switzerland)
Published: April 06, 2022
Robotic surgery training during general surgery residency: a survey comparing attitudes towards a robotic training curriculum within general surgery, urology, and OBGYN residents and attendings.
Journal: Journal of robotic surgery
Published: August 27, 2021
Impact of EcSOD Perturbations in Cancer Progression.
Journal: Antioxidants (Basel, Switzerland)
Published: June 29, 2021
Catalase Modulates the Radio-Sensitization of Pancreatic Cancer Cells by Pharmacological Ascorbate.
Journal: Antioxidants (Basel, Switzerland)
Published: March 17, 2021
The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer.
Journal: Oncogene
Published: November 02, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026